Insight Capital Research & Management’s AbbVie ABBV Stock Holding History

Insight Capital Research & Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$2.27M	Buy	+25,551	New	+$1.95M	1.28%	28
2015 Q1	–	Sell	-29,212	Closed	-$1.91M	–	116
2014 Q4	$1.91M	Sell	29,212 -151	-0.5%	-$9.52K	0.49%	86
2014 Q3	$1.7M	Buy	29,363 +198	+0.7%	+$11K	0.44%	77
2014 Q2	$1.65M	Sell	29,165 -83	-0.3%	-$4.35K	0.38%	83
2014 Q1	$1.5M	Buy	29,248 +2,246	+8%	+$114K	0.35%	89
2013 Q4	$1.43M	Buy	27,002 +99	+0.4%	+$4.87K	0.32%	94
2013 Q3	$1.3M	Sell	26,903 -15,852	-37%	-$703K	0.32%	87
2013 Q2	$1.77M	Buy	+42,755	New	+$1.87M	0.46%	79

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Insight Capital Research & Management's ABBV Position: Q3 2017 in Review

Insight Capital Research & Management opened a new position in AbbVie (ABBV) in Q3 2017: 25,551 shares worth $2.27M. The stake represents 1.28% of the portfolio and ranks #28 among its holdings. This is a return to the name: Insight Capital Research & Management previously reported a position in ABBV as recently as Q4 2014.

Insight Capital Research & Management first reported a position in ABBV in Q2 2013 and has held it in 8 quarters since. 1,797 funds tracked by Wall St. Rank hold ABBV as of Q3 2017.

Insight Capital Research & Management held 25,551 shares of AbbVie worth $2.27M as of Q3 2017.
AbbVie was a new Insight Capital Research & Management position in Q3 2017.
AbbVie made up 1.28% of Insight Capital Research & Management's portfolio in Q3 2017, its #28 holding.
Insight Capital Research & Management first reported a position in AbbVie in Q2 2013 and has held it in 8 quarters since.
1,797 funds tracked by Wall St. Rank held AbbVie as of Q3 2017.

Based on Insight Capital Research & Management's 13F filing for Q3 2017, filed 15 Nov 2017.